This article summarizes the key insights from the Roots Analysis report, focusing on market size, growth drivers, segmentation, challenges, and leading players.

Market Growth Projections

The global vaccines market is currently valued at $48 billion and is projected to reach $94 billion by 2030, representing a compound annual growth rate (CAGR) of 11.9% during the forecast period. Notably, these figures exclude COVID-19 vaccine sales, reflecting the underlying demand for vaccines targeting a broad spectrum of infectious diseases[4].

Drivers of Growth

Several factors are fueling the expansion of the vaccines market:

- Increasing Incidence of Infectious Diseases: Outbreaks of diseases such as Avian influenza A, Mpox, dengue, and rotavirus have underscored the need for advanced vaccines. For example, nearly 4.5 million cases of dengue were reported globally in 2023, with around 4,000 deaths confirmed.
- Government Initiatives: Public health organizations and governments are launching immunization programs and investing in vaccine production. For instance, a $1.1 billion project was announced to accelerate vaccine production in Africa, and partnerships like Biovac and Sanofi are expanding polio vaccine manufacturing across the continent.
- Technological Advancements: The development of next-generation vaccines, including mRNA, recombinant, and DNA vaccines, is enabling faster, safer, and more effective immunization solutions.

Market Segmentation

The vaccines market is segmented across multiple dimensions:

By Type of Vaccine API

- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Others

Live attenuated vaccines currently hold the largest market share (28% in 2024), while other types, including DNA vaccines, are expected to grow at a higher CAGR due to ongoing research and innovation.

By Targeted Patient Population

- Pediatric: Accounts for the largest share (56% in 2024), driven by government immunization programs and the focus on protecting children from preventable diseases.
- Adult: Expected to grow at a higher CAGR (12.1%) due to increasing cases of endemic and pandemic diseases among adults.

By Route of Administration

- Intramuscular: Dominates the market (52% in 2024), favored for its ease of administration and safety profile.
- Subcutaneous, Oral, Intravenous, and Others: The intravenous segment is projected to grow at the highest CAGR (14.6%) during the forecast period.

By Type of Vaccines

- Pneumococcal Conjugate Vaccine
- Human Papillomavirus Vaccine
- Rotavirus Vaccine
- Influenza Vaccine
- MMR Vaccine
- Tetanus and Diphtheria Booster Vaccine
- Varicella Vaccine
- DTaP-Hib-IPV Vaccine
- DTaP-HepB-Hib-IPV Vaccine
- Others

The "others" segment leads the market (32.4% in 2024), followed by pneumococcal conjugate vaccines (25.8%). MMR vaccines are expected to grow at the highest CAGR (12.3%).

By Geographical Region

- North America: Holds the largest market share (44% in 2024), driven by strong healthcare infrastructure and robust immunization programs.
- Europe, Asia-Pacific, Rest of the World: Asia-Pacific is projected to grow at the highest CAGR (14.7%), supported by government partnerships and expanding immunization coverage.

Application Areas

Vaccines are primarily used to prevent infectious diseases, with a growing focus on next-generation solutions for complex conditions such as COVID-19, Ebola, HIV/AIDS, malaria, and Zika. The market also includes therapeutic vaccines targeting cancer and other chronic diseases.

Challenges

Despite strong growth, the vaccines market faces several challenges:

- Operational Challenges: Vaccine production and distribution require specialized infrastructure, skilled personnel, and strict temperature control, particularly in developing regions.
- High Costs: The complexity of vaccine development and the need for cold chain logistics increase overall costs.
- Low Acceptance: Misinformation, complacency, and lack of awareness can hinder vaccine adoption, necessitating public education campaigns.

Key Players

Leading companies in the global vaccines market include:

- Bio Farma
- Emergent BioSolutions
- GC Pharma
- GlaxoSmithKline
- *

Thank you for reading Roots Analysis report. Kindly get in touch with Roots’ team to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services across industries. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact Details

Roots Analysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/